Remdesivir  

 A bench headed by Chief Justice SA Bobde issued notice to the Centre on the plea and sought its response in four weeks

 US President Donald Trump, who was shifted to a hospital after testing positive for COVID-19, is undergoing Remdesivir therapy.
 

Remdesivir is approved by Drug Controller General of India (DCGI) for restricted emergency use in India for the treatment of COVID-19 patients hospitalized with severe symptoms.
 

Increase in death rate forced the Karnataka government to direct all private hospitals across the state not to charge patients admitted at their hospitals. The state will provide the Remdesivir injection free of cost for the treatment of serious and very serious Covid-19 in-patients.

 Zydus is the fifth company to launch a copy of the antiviral in India after privately held Hetero Labs Ltd, Cipla, Mylan NV and Jubilant Life Sciences Ltd
 

The aim is to ensure that their availability is not skewed and does not remain confined to metropolitan areas, an official said.
 

 Favipiravir and another antiviral treatment, remdesivir, have emerged as the most sought-after medicines to treat COVID-19 in India
 

Hetero healthcare will supply 12,500 vials of generic Remdesvir to Maharashtra, 10,000 to Delhi and 9,000 to Telangana out of the 65,000 vials it will produce

The solidarity trial was established by the WHO to find an effective coronavirus treatment for patients. It began with five arms looking at possible treatments.

Gilead Sciences Inc has priced its COVID-19 drug Remdesivir at $2,340 for a five-day treatment in the United States and some other developed countries

Covifor is a generic brand of Remdesivir which is used for the treatment of COVID-19 in adults and children hospitalised with strong symptoms of the disease
 

Remdesivir, which is administered intravenously in hospital, is the first drug to show improvement in COVID-19 patients in formal clinical trials and is at the forefront of the battle against COVID-19, which has no approved treatment or vaccine.

The conditional marketing authorisation for remdesivir was granted under the accelerated review process considering the emergency situation and unmet medical needs

Japan and the United States are the only countries to authorise use of remdesivir for treatment of COVID-19
 

The Hyderabad-based Indian Institute of Chemical Technology has synthesised the key materials for Remdesivir, believed to treat COVID-19